ID Source | ID |
---|---|
PubMed CID | 11485425 |
CHEMBL ID | 177749 |
SCHEMBL ID | 21067750 |
MeSH ID | M0232390 |
Synonym |
---|
(3r)-3-(fluoromethyl)-7-(thiomorpholin-4-ylsulfonyl)-1,2,3,4-tetrahydroisoquinoline |
F21 , |
DB07739 |
(r)-3-fluoromethyl-7-(thiomorpholine-4-sulfonyl)-1,2,3,4-tetrahydro-isoquinoline |
bdbm50163110 |
CHEMBL177749 , |
'3-fluoromethyl 7-thiomorpholinosulfonamide 1,2,3,4-tetrahydroisoquinoline' |
Q27096957 |
SCHEMBL21067750 |
PD005507 |
Protein | Taxonomy | Measurement | Average | Min (ref.) | Avg (ref.) | Max (ref.) | Bioassay(s) |
---|---|---|---|---|---|---|---|
Phenylethanolamine N-methyltransferase | Homo sapiens (human) | Ki | 0.6100 | 0.0016 | 1.3529 | 6.9000 | AID239480 |
Alpha-2A adrenergic receptor | Rattus norvegicus (Norway rat) | Ki | 200.0000 | 0.0000 | 0.9375 | 10.0000 | AID238890 |
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |
Process | via Protein(s) | Taxonomy |
---|---|---|
methylation | Phenylethanolamine N-methyltransferase | Homo sapiens (human) |
epinephrine biosynthetic process | Phenylethanolamine N-methyltransferase | Homo sapiens (human) |
catecholamine biosynthetic process | Phenylethanolamine N-methyltransferase | Homo sapiens (human) |
[Information is prepared from geneontology information from the June-17-2024 release] |
Process | via Protein(s) | Taxonomy |
---|---|---|
phenylethanolamine N-methyltransferase activity | Phenylethanolamine N-methyltransferase | Homo sapiens (human) |
protein binding | Phenylethanolamine N-methyltransferase | Homo sapiens (human) |
[Information is prepared from geneontology information from the June-17-2024 release] |
Process | via Protein(s) | Taxonomy |
---|---|---|
cytosol | Phenylethanolamine N-methyltransferase | Homo sapiens (human) |
cytosol | Phenylethanolamine N-methyltransferase | Homo sapiens (human) |
[Information is prepared from geneontology information from the June-17-2024 release] |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 5 (71.43) | 18.2507 |
2000's | 1 (14.29) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (14.29) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.
| This Compound (65.32) All Compounds (24.57) |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 7 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |